Other languages Fortress Biotech, Inc.

Equities

FBIO

US34960Q3074

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
1.95 ^USD	+1.04%		+14.71%	-35.22%

May. 15	Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M	MT
May. 14	Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex	May. 14
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation	May. 14
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Eric Rowinsky Announces Not Stand for Re-Election to the Board of Fortress Biotech, Inc	Jan. 26
Fortress Biotech Prices $11 Million Offering of Stock, Warrants; Shares Sink in Early Trading	Dec. 29
Top Midday Gainers	Nov. 17
Fortress Biotech Insider Bought Shares Worth $2,664,776, According to a Recent SEC Filing	Nov. 16
Fortress Biotech Insider Bought Shares Worth $249,999, According to a Recent SEC Filing	Nov. 16
Fortress Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks	Nov. 10
Top Premarket Decliners	Nov. 10
Fortress Biotech Begins Public Offering of Units	Nov. 10
Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 Mg) Vs. Solodyn (Minocycline Hydrochine Hydrochloride Extended-Release Tablets, 105 Mg)	23-10-20
Fortress Biotech Announces 1-for-15 Reverse Stock Split	23-10-09
Fortress Biotech CEO Rosenwald Buys 20,000 Shares for $210,900	23-08-21
Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Fortress Biotech Unit Urica Says Study of Dotinurad Shows Comparable Profile Between Healthy US, Japanese Subjects	23-06-29
Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
Fortress Biotech Closes $13.9 Million Registered Direct Offering	23-02-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Fortress Biotech, Inc.

Equities

FBIO

US34960Q3074

Other languages

Filters